DK35887A - Benzazecinderivater - Google Patents

Benzazecinderivater

Info

Publication number
DK35887A
DK35887A DK035887A DK35887A DK35887A DK 35887 A DK35887 A DK 35887A DK 035887 A DK035887 A DK 035887A DK 35887 A DK35887 A DK 35887A DK 35887 A DK35887 A DK 35887A
Authority
DK
Denmark
Prior art keywords
chloro
cpds
acetyl
benzazecine
methoxybenzoyl
Prior art date
Application number
DK035887A
Other languages
Danish (da)
English (en)
Other versions
DK35887D0 (da
Inventor
Werner Aschwanden
Rene Imhof
Roland Jakob
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK35887D0 publication Critical patent/DK35887D0/da
Publication of DK35887A publication Critical patent/DK35887A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
    • C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D227/08—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK035887A 1986-01-23 1987-01-22 Benzazecinderivater DK35887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH26686 1986-01-23

Publications (2)

Publication Number Publication Date
DK35887D0 DK35887D0 (da) 1987-01-22
DK35887A true DK35887A (da) 1987-07-24

Family

ID=4183090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK035887A DK35887A (da) 1986-01-23 1987-01-22 Benzazecinderivater

Country Status (30)

Country Link
US (4) US4732979A (fr)
EP (1) EP0230967B1 (fr)
JP (1) JPS62169770A (fr)
KR (1) KR910000659B1 (fr)
CN (1) CN1013111B (fr)
AT (1) ATE68790T1 (fr)
AU (1) AU590042B2 (fr)
CS (1) CS258147B2 (fr)
DD (1) DD264431A5 (fr)
DE (1) DE3773950D1 (fr)
DK (1) DK35887A (fr)
FI (1) FI82931C (fr)
GB (1) GB2185744B (fr)
HU (1) HU197883B (fr)
IE (1) IE870167L (fr)
IL (1) IL81317A (fr)
IS (1) IS3190A7 (fr)
MC (1) MC1795A1 (fr)
MT (1) MTP996B (fr)
MW (1) MW187A1 (fr)
NO (1) NO167385C (fr)
NZ (1) NZ218987A (fr)
OA (1) OA08469A (fr)
PH (1) PH22879A (fr)
PL (1) PL263796A1 (fr)
PT (1) PT84181B (fr)
TN (1) TNSN87006A1 (fr)
YU (1) YU7087A (fr)
ZA (1) ZA87407B (fr)
ZW (1) ZW1087A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them
IN167395B (fr) * 1987-07-21 1990-10-20 Hoffmann La Roche
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
ES2169026T3 (es) * 1991-08-21 2002-07-01 Lilly Co Eli Benzo(f)quinolinonas como inhibidores de 5-alfa-reductasa.
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
ES2125884T3 (es) * 1991-08-21 1999-03-16 Lilly Co Eli Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
WO1994022444A1 (fr) * 1993-03-29 1994-10-13 Smithkline Beecham Corporation Composes tricycliques utilises pour inhiber l'agregation plaquettaire
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
DE69515321T2 (de) * 1994-09-20 2000-08-24 The Regents Of The University Of California, Oakland Brefeldin a und analoge zur verbesserung synaptischer übertragungen
US20050067341A1 (en) * 2003-09-25 2005-03-31 Green Dennis H. Continuous production membrane water treatment plant and method for operating same
US7094331B2 (en) * 2003-11-05 2006-08-22 Marathon Ashland Petroleum Llc Viscosity modification of heavy hydrocarbons using dihydric alcohols
US20090263439A1 (en) * 2008-04-18 2009-10-22 The Procter & Gamble Company Antimicrobial Preservative Free Wipe
CN106117028B (zh) * 2016-06-14 2019-01-01 浙江永太药业有限公司 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE442586A (fr) * 1940-07-31
JPS5129710B2 (fr) * 1972-09-09 1976-08-27
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
US4521423A (en) * 1983-10-31 1985-06-04 Ayerst, Mckenna & Harrison, Ltd. 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
IL81317A (en) * 1986-01-23 1991-06-30 Hoffmann La Roche 1,2,4,5,6,7-hexahydro-4-benzazecine-3,8-dione derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT84181A (pt) 1987-02-01
ATE68790T1 (de) 1991-11-15
NO870280D0 (no) 1987-01-22
CS41887A2 (en) 1987-11-12
IS3190A7 (is) 1987-07-24
FI82931C (fi) 1991-05-10
DK35887D0 (da) 1987-01-22
NO167385C (no) 1991-10-30
US4732979A (en) 1988-03-22
PT84181B (pt) 1989-09-14
JPS62169770A (ja) 1987-07-25
CN87100312A (zh) 1987-09-09
MC1795A1 (fr) 1987-10-22
GB8701416D0 (en) 1987-02-25
EP0230967A2 (fr) 1987-08-05
GB2185744A (en) 1987-07-29
NO870280L (no) 1987-07-24
IE870167L (en) 1987-07-23
PH22879A (en) 1989-01-19
US4749791A (en) 1988-06-07
NO167385B (no) 1991-07-22
KR910000659B1 (ko) 1991-01-31
MTP996B (en) 1987-08-21
PL263796A1 (en) 1988-10-27
YU7087A (en) 1988-06-30
EP0230967B1 (fr) 1991-10-23
US4957911A (en) 1990-09-18
OA08469A (fr) 1988-07-29
MW187A1 (en) 1987-10-14
AU6791187A (en) 1987-07-30
KR870007132A (ko) 1987-08-17
ZA87407B (en) 1987-09-30
CN1013111B (zh) 1991-07-10
DE3773950D1 (de) 1991-11-28
EP0230967A3 (en) 1988-08-31
CS258147B2 (en) 1988-07-15
TNSN87006A1 (fr) 1990-01-01
HUT44519A (en) 1988-03-28
IL81317A0 (en) 1987-08-31
FI870220A0 (fi) 1987-01-20
GB2185744B (en) 1989-12-06
US4876340A (en) 1989-10-24
HU197883B (en) 1989-06-28
ZW1087A1 (en) 1987-08-12
DD264431A5 (de) 1989-02-01
FI870220A7 (fi) 1987-07-24
FI82931B (fi) 1991-01-31
IL81317A (en) 1991-06-30
AU590042B2 (en) 1989-10-26
NZ218987A (en) 1990-04-26

Similar Documents

Publication Publication Date Title
AU590042B2 (en) Benzazecine Derivatives
NO164093C (no) Pyridinoksyd-mellomprodukter og fremgangsmaate for deres fremstilling.
NO920494D0 (no) Terapeutiske, heterosykliske forbindelser
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
FI812635L (fi) Piperidylidenderivat deras framstaellning och dessa innehaollande farmaceutiska blandningar
NO885210L (no) Anvendelse av cellulosederivater i borspylinger.
FI861704A0 (fi) Tricykliska oxindol-antiinflammatoriska aemnen.
FI884345A0 (fi) Sackaridderivat.
NO911798L (no) 3'-deamino-4'-deoksy-4'-amino-8-fluorantracykliner og deres fremstilling.
GR880100042A (el) Παραγωγα πυλοκαρπινης
FI901459A0 (fi) In vitro-syntes av ingripande rna.
GR880100196A (el) Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους
ES2059097T3 (es) Derivados de la ergolina.
RO96381A2 (fr) Procede pour la synthese d'azobiscyclopentancarbonitryle
GR1000138B (el) Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων.
ATE98679T1 (de) Herstellung des hblv-virus in der hsb-2 zelllinie.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment